{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:16:36Z","timestamp":1781180196746,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11883-024-01253-z","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T03:09:58Z","timestamp":1733108998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Highlights of Cardiovascular Disease Prevention Studies\u00a0Presented at the 2024 European Society of Cardiology\u00a0Congress"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3161-7508","authenticated-orcid":false,"given":"Vashma","family":"Junaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Mannan Khan","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Inam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hinkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawaja M.","family":"Talha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Meloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Khoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Slipczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"issue":"8","key":"1253_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11883-024-01218-2","volume":"26","author":"K Gupta","year":"2024","unstructured":"Gupta K, Rawlley B, Meloche C, Minhas AMK, Hermel M, Slipczuk L, et al. Highlights of Cardiovascular Disease Prevention studies presented at the 2024 American College of Cardiology Conference. Curr Atheroscler Rep. 2024;26(8):367\u201381.","journal-title":"Curr Atheroscler Rep"},{"issue":"12","key":"1253_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11883-023-01164-5","volume":"25","author":"K Gupta","year":"2023","unstructured":"Gupta K, Hinkamp C, Andrews T, Meloche C, Minhas AMK, Slipczuk L, et al. Highlights of Cardiovascular Disease Prevention studies presented at the 2023 European Society of Cardiology Congress. Curr Atheroscler Rep. 2023;25(12):965\u201378.","journal-title":"Curr Atheroscler Rep"},{"issue":"17","key":"1253_CR3","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJMoa2400969","volume":"390","author":"CM Gibson","year":"2024","unstructured":"Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, et al. Apolipoprotein A1 infusions and Cardiovascular outcomes after Acute myocardial infarction. N Engl J Med. 2024;390(17):1560\u201371.","journal-title":"N Engl J Med"},{"key":"1253_CR4","doi-asserted-by":"publisher","unstructured":"Apolipoprotein A-I, Infusions, and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels. : The AEGIS-II Trial | European Heart Journal | Oxford Academic [Internet]. [cited 2024 Sep 12]. https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/https:\/\/doi.org\/10.1093\/eurheartj\/ehae614\/7745365","DOI":"10.1093\/eurheartj\/ehae614\/7745365"},{"key":"1253_CR5","doi-asserted-by":"publisher","unstructured":"Watts GF, Rosenson RS, Hegele RA, Goldberg IJ, Gallo A, Mertens A et al. Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk. N Engl J Med [Internet]. [cited 2024 Sep 12];0(0). https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa2409368","DOI":"10.1056\/NEJMoa2409368"},{"issue":"9","key":"1253_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurjpc\/zwae040","volume":"31","author":"AM Khan Minhas","year":"2024","unstructured":"Khan Minhas AM, Sedhom R, Jean ED, Shapiro MD, Panza JA, Alam M, et al. Global burden of cardiovascular disease attributable to smoking, 1990\u20132019: An analysis of the 2019 global burden of disease study. Eur J Prev Cardiol. 2024;31(9):1123\u201331.","journal-title":"Eur J Prev Cardiol"},{"key":"1253_CR7","doi-asserted-by":"publisher","unstructured":"Ridker PM, Moorthy MV, Cook NR, Rifai N, Lee IM, Buring JE, Inflammation. Cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women. N Engl J Med [Internet]. [cited 2024 Sep 12];0(0). https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa2405182","DOI":"10.1056\/NEJMoa2405182"},{"key":"1253_CR8","doi-asserted-by":"publisher","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the management of patients with chronic coronary disease. 2023 : A Report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines. Circulation [Internet]. 2023 Aug 29 [cited 2024 Sep 15];148(9). https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000001168","DOI":"10.1161\/CIR.0000000000001168"},{"issue":"1","key":"1253_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"27","key":"1253_CR10","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","volume":"39","author":"F Mach","year":"2018","unstructured":"Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, et al. Adverse effects of statin therapy: perception vs. the evidence \u2013 focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39(27):2526\u201339.","journal-title":"Eur Heart J"},{"key":"1253_CR11","doi-asserted-by":"crossref","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ et al. ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73(24):e285\u2013350.","DOI":"10.1016\/j.jacc.2018.11.003"},{"key":"1253_CR12","doi-asserted-by":"crossref","unstructured":"Gobbel GT, Matheny ME, Reeves RR, Akeroyd JM, Turchin A, Ballantyne CM, et al. Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease. Am J Prev Cardiol. 2022;9:100300.","DOI":"10.1016\/j.ajpc.2021.100300"},{"issue":"10349","key":"1253_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","volume":"400","author":"BK Kim","year":"2022","unstructured":"Kim BK, Hong SJ, Lee YJ, Hong SJ, Yun KH, Hong BK, et al. Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): A randomised, open-label, non-inferiority trial. Lancet. 2022;400(10349):380\u201390.","journal-title":"Lancet"},{"key":"1253_CR14","doi-asserted-by":"crossref","unstructured":"Lee YJ, Hong SJ, Kang WC, Hong BK, Lee JY, Lee JB et al. Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial. BMJ. 2023;e075837.","DOI":"10.1136\/bmj-2023-075837"},{"issue":"13","key":"1253_CR15","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jama.2023.2487","volume":"329","author":"SJ Hong","year":"2023","unstructured":"Hong SJ, Lee YJ, Lee SJ, Hong BK, Kang WC, Lee JY, et al. Treat-to-target or high-intensity statin in patients with coronary artery disease: a Randomized Clinical Trial. JAMA. 2023;329(13):1078.","journal-title":"JAMA"},{"key":"1253_CR16","doi-asserted-by":"publisher","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: A report of the American college of cardiology\/American heart association task force on clinical practice Guidelines. Circulation [Internet]. 2019 Sep 10 [cited 2024 Sep 19];140(11). https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000000678","DOI":"10.1161\/CIR.0000000000000678"},{"issue":"25","key":"1253_CR17","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1161\/CIRCULATIONAHA.111.065490","volume":"125","author":"JM Bachmann","year":"2012","unstructured":"Bachmann JM, Willis BL, Ayers CR, Khera A, Berry JD. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study. Circulation. 2012;125(25):3092\u20138.","journal-title":"Circulation"},{"issue":"12","key":"1253_CR18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.jcmg.2017.09.003","volume":"11","author":"JD Mitchell","year":"2018","unstructured":"Mitchell JD, Paisley R, Moon P, Novak E, Villines TC. Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke. JACC Cardiovasc Imaging. 2018;11(12):1799\u2013806.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"32","key":"1253_CR19","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38(32):2459\u201372.","journal-title":"Eur Heart J"},{"issue":"25","key":"1253_CR20","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after Acute Coronary syndromes. N Engl J Med. 2015;372(25):2387\u201397.","journal-title":"N Engl J Med"},{"key":"1253_CR21","doi-asserted-by":"crossref","unstructured":"Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097\u2013107.","DOI":"10.1056\/NEJMoa1801174"},{"issue":"44","key":"1253_CR22","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1093\/eurheartj\/ehz826","volume":"41","author":"to Corrigendum","year":"2020","unstructured":"Corrigendum to. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(44):4255\u20134255.","journal-title":"Eur Heart J"},{"key":"1253_CR23","doi-asserted-by":"crossref","unstructured":"Schubert J, Leosdottir M, Lindahl B, Westerbergh J, Melhus H, Modica A et al. Intensive early and sustained lowering of non\u2013high-density lipoprotein cholesterol after myocardial infarction and prognosis: The SWEDEHEART registry. Eur Heart J. 2024;ehae576.","DOI":"10.1093\/eurheartj\/ehae576"},{"key":"1253_CR24","doi-asserted-by":"crossref","unstructured":"Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, et al. NHLBI Working group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol. 2018;71(2):177\u201392.","DOI":"10.1016\/j.jacc.2017.11.014"},{"key":"1253_CR25","doi-asserted-by":"crossref","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: A European atherosclerosis society consensus statement. Eur Heart J. 2022;43(39):3925\u201346.","DOI":"10.1093\/eurheartj\/ehac361"},{"key":"1253_CR26","doi-asserted-by":"crossref","unstructured":"McEvoy JW, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I et al. Variation in secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study. Eur Heart J. 2024;ehae558.","DOI":"10.1093\/eurheartj\/ehae558"},{"key":"1253_CR27","doi-asserted-by":"crossref","unstructured":"Byty\u00e7i I, Penson PE, Mikhailidis DP, Wong ND, Hernandez AV, Sahebkar A, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213\u201323.","DOI":"10.1093\/eurheartj\/ehac015"},{"key":"1253_CR28","doi-asserted-by":"crossref","unstructured":"Serban MC, Colantonio LD, Manthripragada AD, Monda KL, Bittner VA, Banach M, et al. Statin intolerance and risk of coronary heart events and all-cause Mortality following myocardial infarction. J Am Coll Cardiol. 2017;69(11):1386\u201395.","DOI":"10.1016\/j.jacc.2016.12.036"},{"issue":"Supplement1","key":"1253_CR29","doi-asserted-by":"publisher","first-page":"i56","DOI":"10.1093\/eurheartjsupp\/suae007","volume":"26","author":"M Ruscica","year":"2024","unstructured":"Ruscica M, Bertoletti A, Gobbi C, Sirtori CR, Carugo S, Corsini A. Lipid-lowering approaches to manage statin-intolerant patients. Eur Heart J Suppl. 2024;26(Supplement1):i56\u20139.","journal-title":"Eur Heart J Suppl"},{"issue":"3","key":"1253_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/joim.13333","volume":"290","author":"M Guasch-Ferr\u00e9","year":"2021","unstructured":"Guasch-Ferr\u00e9 M, Willett WC. The Mediterranean diet and health: A comprehensive overview. J Intern Med. 2021;290(3):549\u201366.","journal-title":"J Intern Med"},{"issue":"10","key":"1253_CR31","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1017\/S136898001100351X","volume":"15","author":"C Mithril","year":"2012","unstructured":"Mithril C, Dragsted LO, Meyer C, Blauert E, Holt MK, Astrup A. Guidelines for the New Nordic Diet. Public Health Nutr. 2012;15(10):1941\u20137.","journal-title":"Public Health Nutr"},{"issue":"28","key":"1253_CR32","first-page":"V09130558","volume":"176","author":"C Bork","year":"2014","unstructured":"Bork C, Jakobsen MU, Schmidt EB. [Mediterranean diet and cardiovascular disease]. Ugeskr Laeger. 2014;176(28):V09130558.","journal-title":"Ugeskr Laeger"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-024-01253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-024-01253-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-024-01253-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:32:16Z","timestamp":1758796336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-024-01253-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1007\/s11883-024-01253-z","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"2 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Virani is a Section Editor for the Springer journals Current Atherosclerosis Reports and Current Cardiology Reports. Dr. Slipczuk has received consulting honorarium from Amgen and Philips, participated in the advisory board for Bristol-Myers-Squib, and serves as site PI for V-INITIATE and Ocean(a) trials. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Financial Declarations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Dr. Virani is supported by the Department of Veterans Affairs, NIH, NIHR UK, Tahir, and Jooma Family Foundation. Dr. Slipczuk has received institutional grants from Amgen and Philips.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"14"}}